1. Clinical Diagnosis

   • I. Ralph Edwards

   Editorial 09 January 2013 Pages: 261 - 264

2. Embedding ‘Speaking Up’ into Systems for Safe Healthcare Product Development and Marketing Surveillance

   • Brian Edwards
   • Bruce Hugman
   • Matthew Whalen

   Current Opinion 09 January 2013 Pages: 265 - 271

3. Safety of Flecainide

   • Juan Tamargo
   • Alessandro Capucci
   • Philippe Mabo

   Review Article 09 January 2013 Pages: 273 - 289

   

4. Deriving Dose Limits for Warnings in Electronic Prescribing Systems

   • Jamie J. Coleman
   • James Hodson
   • Robin E. Ferner

   Short Communication 09 January 2013 Pages: 291 - 298

   

5. Risk Minimization Activities of Centrally Authorized Products in the EU

   • Inge M. Zomerdijk
   • Fakhredin A. Sayed-Tabatabaei
   • Sabine M. J. M. Straus

   Original Research Articles 09 January 2013 Pages: 299 - 314

   

6. Cardiovascular, Ocular and Bone Adverse Reactions Associated with Thiazolidinediones

   • Domenico Motola
   • Carlo Piccinni
   • Elisabetta Poluzzi

   Original Research Articles 09 January 2013 Pages: 315 - 323

   

7. Assessing Opioid Shopping Behaviour

   • M. Soledad Cepeda
   • Daniel Fife
   • Scott C. Henderson

   Original Research Articles 09 January 2013 Pages: 325 - 334

   

8. Vaccine-Based Subgroup Analysis in VigiBase

   • Sandra de Bie
   • Katia M. C. Verhamme
   • on behalf of the TEDDY European Network of Excellence

   Original Research Articles 09 January 2013 Pages: 335 - 346